Ge Long Hui A P P·2025-08-06 10:19Core Viewpoint - BeiGene (688235.SH) expects its revenue for 2025 to be between RMB 35.8 billion and RMB 38.1 billion, indicating a positive growth outlook for the company [1] Financial Projections - The total expected R&D expenses, along with sales and management expenses, are projected to be between RMB 29.5 billion and RMB 31.9 billion, consistent with previous adjustments [1] - The gross margin is anticipated to be in the mid-to-high range of 80% to 90%, which is an upward adjustment from prior estimates [1] Cash Flow Expectations - The company forecasts that its annual revenue will exceed the total of its operating costs, sales expenses, management expenses, and R&D expenses [1] - The net cash flow from operating activities, after deducting capital expenditures for fixed asset purchases, is expected to be positive [1]